Meet our expert Anna Sandholm
“My first thought when I come into contact with a new drug is; what happens with the drug after intake, how will it be metabolised? Drug metabolites must be accounted for, both from a safety and efficacy perspective”.
Drug metabolism and pharmacokinetics are important elements of the preclinical strategy. “The mix of science and strategic planning while adhering to the demands in regulatory guidelines makes my job challenging and rewarding”.
Dr Anna Sandholm brings 10 years of experience from Astra Zeneca and seven years as senior advisor in SDS within the field of drug metabolism and pharmacokinetics.
How can she assist you?